The Economic Burden of Adults with Major Depressive Disorder in the United States (2010 and 2018)

Andrée-Anne Fournier, Tammy Sisitsky, Mark Simes, Richard Berman, Sarah H. Koenigsberg, Ronald C. Kessler

PharmacoEconomics · 2021 · 773 citations · 26 references

DOIFull text

Open access

Abstract

Workplace costs accounted for the largest portion of the growing economic burden of MDD as this population trended younger and was increasingly likely to be employed. Although the total number of adults with MDD increased from 2010 to 2018, the incremental direct cost per individual declined. At the same time, the proportion of adults with MDD who received treatment remained stable over the past decade, suggesting that substantial unmet treatment needs remain in this population. Further research is warranted into the availability, composition, and quality of MDD treatment services.

References

26